Papers: 7 Mar 2014 - 14 Mar 2014
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): A single case report follow-up study.
Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
Effect of seasonal fluctuation of ambient temperature on fatigue in multiple sclerosis patients living in Attica, Greece.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Is walking capacity in subjects with multiple sclerosis primarily related to muscle oxidative capacity or maximal muscle strength? A pilot study.
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.